Amendment No. 7 to Receivables Purchase Agreement

EXHIBIT 10.13

AMENDMENT NO. 7 TO RECEIVABLES PURCHASE AGREEMENT
AND
AMENDMENT NO. 5 TO PERFORMANCE UNDERTAKING

          THIS AMENDMENT (this “Amendment”) is entered into as of January 14, 2005, among Ceridian Corporation, a Delaware corporation (“Ceridian” or “Performance Guarantor”), Comdata Funding Corporation, a Delaware corporation (“Seller”), Comdata Network, Inc., a Maryland corporation (the “Servicer”) (the Servicer together with Seller, the “Seller Parties” and each a “Seller Party”), each Financial Institution party hereto (the “Financial Institutions”), Jupiter Securitization Corporation (“Jupiter” and, together with the Financial Institutions, the “Purchasers”), and JPMorgan Chase Bank, N.A., successor by merger to Bank One, NA (Main Office Chicago), as agent for the Purchasers (the “Agent”).

RECITALS

     Each of the parties hereto other than Ceridian entered into that certain Receivables Purchase Agreement, dated as of June 24, 2002, as amended by Amendment No. 1 thereto, dated as of June 20, 2003, Amendment No. 2, dated as of June 17, 2004, Amendment No. 3, dated as of August 4, 2004, Amendment No. 4, dated as of September 30, 2004, Amendment No. 5, dated as of November 9, 2004 and Amendment No. 6, dated as of December 31, 2004 (such agreement, as so amended, the “Purchase Agreement”).

     Performance Guarantor entered into that certain Performance Undertaking dated as of June 24, 2002, in favor of Seller, as amended by Amendment No. 1 thereto, dated as of August 4, 2004, Amendment No. 2, dated as of September 30, 2004, Amendment No. 3, dated as of November 9, 2004 and Amendment No. 4, dated as of December 31, 2004 (such undertaking, as so amended, the “Performance Undertaking”).

     Ceridian has advised the Agent that because of the review of certain capitalization and expensing procedures as disclosed in Ceridian’s press releases dated July 19, 2004, August 5, 2004, September 30, 2004 and October 18, 2004, it has determined that it may not be able to file with the Securities and Exchange Commission (“SEC”) its quarterly reports on Form 10-Q with respect to the fiscal quarter ending June 30, 2004 and September 30, 2004 within the time periods contemplated by Amendment No. 6 to Receivables Purchase Agreement and Amendment No. 4 to Performance Undertaking dated as of December 31, 2004, and Ceridian and the Seller Parties have requested that the Agent and the Purchasers agree to certain potential amendments of the Purchase Agreement and the Performance Undertaking to accommodate the possibility that Ceridian will not be able to make such filings within such time periods.

     Subject to the terms and conditions hereof, each of the parties hereto now desires to amend the Purchase Agreement and the Performance Undertaking as particularly described herein.

AGREEMENT

          NOW, THEREFORE, in consideration of the premises, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:

          Section 1. Definitions Used Herein. Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth for such terms in the Purchase Agreement or the Performance Undertaking, as applicable.

          Section 2. Amendments. Subject to the terms and conditions hereinafter set forth:

          (a) The definition of “Material Adverse Effect” appearing in Exhibit I to the Purchase Agreement is hereby amended to add the following new sentence at the end thereof:

     It is understood and agreed that none of the following, individually or in the aggregate, will constitute a Material Adverse Effect: (a) any delay in filing Ceridian’s quarterly report on Form 10-Q filed with the SEC for the fiscal quarters of Ceridian ending June 30, 2004 and September 30, 2004, which does not extend to a date later than February 28, 2005; (b) the determination by Ceridian that a restatement is required of financial reports or other information previously required to be delivered under this Agreement with respect to any periods ending before June 30, 2004, as disclosed in Ceridian’s press release dated October 18, 2004, as a result of the review of certain capitalization and expensing procedures at its Human Resources Solutions business, as disclosed in Ceridian’s press releases dated July 19, 2004, August 5, 2004, September 30, 2004, and October 18, 2004 (the “Review”); (c) any such actual restatement which is furnished to the Agent on or before February 28, 2005, to the extent such restatement is not asserted in writing by the Agent on or before fourteen (14) days after the Agent’s receipt thereof to be a material restatement of such previously delivered financial reports or other information; and (d) any effect of the Review on the financial statements furnished to the Agent with respect to either of the fiscal quarters ending June 30, 2004 or September 30, 2004 which are furnished to the Agent on or before February 28, 2005, to the extent such effect is not asserted in writing by the Agent to be a material restatement of such previously delivered financial reports or other information on or before fourteen (14) days after any such effect is communicated in writing to the Agent.

          (b) The definition of “Material Adverse Effect” appearing in Section 1 of the Performance Undertaking is hereby amended to add the following new sentence at the end thereof:

     It is understood and agreed that none of the following, individually or in the aggregate, will constitute a Material Adverse Effect: (a) any delay in filing Performance Guarantor’s quarterly report on Form 10-Q filed with the SEC for the fiscal quarters of Performance Guarantor ending June 30, 2004 and September

2

30, 2004, which does not extend to a date later than February 28, 2005; (b) the determination by Performance Guarantor that a restatement is required of financial reports or other information previously required to be delivered under this Undertaking with respect to any periods ending before June 30, 2004, as disclosed in Performance Guarantor’s press release dated October 18, 2004, as a result of the review of certain capitalization and expensing procedures at its Human Resources Solutions business, as disclosed in Performance Guarantor’s press releases dated July 19, 2004, August 5, 2004, September 30, 2004 and October 18, 2004 (the “Review”); (c) any such actual restatement which is furnished to the Agent on or before February 28, 2005, to the extent such restatement is not asserted in writing by the Recipient (or the Agent, as its assignee) on or before fourteen (14) days after the Agent’s receipt thereof to be a material restatement of such previously delivered financial reports or other information; and (d) any effect of the Review on the financial statements furnished to the Recipient and the Agent with respect to either of the fiscal quarters ending June 30, 2004 or September 30, 2004 which are furnished to the Recipient and the Agent on or before February 28, 2005, to the extent such effect is not asserted in writing by the Recipient (or the Agent, as its assignee) on or before fourteen (14) days after such financial statements are furnished to be a material restatement of such previously delivered financial reports or other information.

          (c) The provisos to Section 7.1(a) of the Purchase Agreement are hereby amended and restated in their collective entirety to read as follows:

     provided, however, that with respect to the fiscal quarters of Ceridian ending June 30, 2004 or September 30, 2004, the Seller Parties will not be required to deliver the reports or other information described above in this Section 7.1(a) until February 28, 2005.

          (d) The provisos to Section 7 of the Performance Undertaking are hereby amended and restated in their collective entirety to read as follows:

     provided, however, that with respect to the fiscal quarters of Performance Guarantor ending June 30, 2004 and September 30, 2004, Performance Guarantor will not be required to deliver the reports or other information described above in this Section 7 until February 28, 2005.

          Section 3. Agreement to Pay Supplemental Fee. In addition to the fee described in Section 4(d) of this Amendment, as an inducement to the Agent and the Purchasers to agree to the amendments set forth in Section 2 above, in the event that the Performance Guarantor has not filed its quarterly report on Form 10-Q filed with the SEC for the fiscal quarters ending June 30, 2004 and September 30, 2004, on or before February 7, 2005, on February 8, 2005, the Performance Guarantor will pay to the Agent a fully-earned and non-refundable supplemental fee of $10,000 (which fee may be shared with the Purchasers in such proportions as the Agent and the Purchasers may agree upon).

3

          Section 4. Condition to Effectiveness of this Amendment. This Amendment shall become effective as of January 14, 2005 when each of the following conditions precedent has been satisfied:

          (a) Amendment. The Agent shall have received, on or before the date hereof, executed counterparts of this Amendment, duly executed by each of the parties hereto.

          (b) Representations and Warranties. As of the date hereof, after giving effect to this Amendment:

          (c) No Amortization Event. As of the date hereof, after giving effect to this Amendment, no Amortization Event or Potential Amortization Event shall have occurred and be continuing (and by its execution hereof, each of the Seller Parties shall be deemed to have represented and warranted such).

          (d) Fee. The Agent shall have received a fully-earned and non-refundable amendment fee of $5,000 in immediately available funds.

          Section 5. Miscellaneous.

          (a) Effect; Ratification. The amendments set forth herein are effective solely for the purposes set forth herein and shall be limited precisely as written, and shall not be deemed to (i) be a consent to any amendment, waiver or modification of any other term or condition of the Performance Undertaking, the Purchase Agreement or of any other instrument or agreement referred to therein or (ii) prejudice any right or remedy which any Purchaser or the Agent may now have or may have in the future under or in connection with the Performance Undertaking or Purchase Agreement as amended hereby or any other instrument or agreement referred to therein. Each reference in the Purchase Agreement to “this Agreement,” “herein,” “hereof” and words of like import and each reference in the other Transaction Documents to the Purchase Agreement or to the “Receivables Purchase Agreement” or to the “Performance Undertaking” shall mean the Purchase Agreement or Performance Undertaking, as the case may be, each as amended hereby. Each reference in the Performance Undertaking to “this Undertaking,” “herein,” “hereof” and words of like import and each reference in the other Transaction

4

Documents to the Performance Undertaking or to the “Purchase Agreement” or “Receivables Purchase Agreement” shall mean the Performance Undertaking or Purchase Agreement, as applicable, each as amended hereby. This Amendment shall be construed in connection with and as part of the Performance Undertaking and Purchase Agreement and all terms, conditions, representations, warranties, covenants and agreements set forth in the Performance Undertaking or Purchase Agreement and each other instrument or agreement referred to therein, except as herein amended, are hereby ratified and confirmed and shall remain in full force and effect.

          (b) Transaction Documents. This Amendment is a Transaction Document executed pursuant to the Purchase Agreement and the Performance Undertaking and shall be construed, administered and applied in accordance with the terms and provisions thereof.

          (c) Costs, Fees and Expenses. Seller agrees to reimburse the Agent and each Purchaser on demand for all costs, fees and expenses (including, without limitation, the reasonable fees and expenses of counsels to the Agent and each Purchaser) incurred in connection with the preparation, execution and delivery of this Amendment.

          (d) Counterparts. This Amendment may be executed in any number of counterparts, each such counterpart constituting an original and all of which when taken together shall constitute one and the same instrument.

          (e) Severability. Any provision contained in this Amendment that is held to be inoperative, unenforceable or invalid in any jurisdiction shall, as to that jurisdiction, be inoperative, unenforceable or invalid without affecting the remaining provisions of this Amendment in that jurisdiction or the operation, enforceability or validity of such provision in any other jurisdiction.

          (f) GOVERNING LAW. THIS AMENDMENT SHALL BE GOVERNED AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF ILLINOIS.

          (g) WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES TRIAL BY JURY IN ANY JUDICIAL PROCEEDING INVOLVING, DIRECTLY OR INDIRECTLY, ANY MATTER (WHETHER SOUNDING IN TORT, CONTRACT OR OTHERWISE) IN ANY WAY ARISING OUT OF, RELATED TO, OR CONNECTED WITH THIS AMENDMENT, ANY DOCUMENT EXECUTED BY ANY SELLER PARTY OR PERFORMANCE GUARANTOR PURSUANT TO THIS AMENDMENT OR THE RELATIONSHIP ESTABLISHED HEREUNDER OR THEREUNDER.

(Signature Pages Follow)

5

          IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed and delivered by their respective duly authorized officers or signatories as of the date first written above.

COMDATA FUNDING CORPORATION, as Seller

COMDATA NETWORK, INC., as Servicer

CERIDIAN CORPORATION, as Performance Guarantor

6

JUPITER SECURITIZATION CORPORATION

JPMORGAN CHASE BANK, N.A., successor by merger to bank one, NA,
as a Financial Institution and as Agent

7